• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

价值在于患者眼中:患者报告结局测量的原因、内容和方法。

Value Lies in the Eye of the Patients: The Why, What, and How of Patient-reported Outcomes Measures.

机构信息

Centre for Research on Health and Social Care Management, SDA Bocconi Government, Health and Not for Profit Division, Milan, Italy; Evidence Synthesis & Modelling for Health Improvement, College of Medicine and Health, University of Exeter Medical School, Exeter, United Kingdom.

Centre for Research on Health and Social Care Management, SDA Bocconi Government, Health and Not for Profit Division, Milan, Italy; School of Engineering, Warwick University, Coventry, United Kingdom.

出版信息

Clin Ther. 2020 Jan;42(1):25-33. doi: 10.1016/j.clinthera.2019.11.016. Epub 2020 Jan 10.

DOI:10.1016/j.clinthera.2019.11.016
PMID:31932079
Abstract

Patient-reported outcomes (PROs) are any report of the status of a patient's health condition that comes directly from the patient (or in some cases from a caregiver or surrogate responder), without interpretation by a practitioner or anyone else. PROs are increasingly used as a valuable source of data in different domains of health care, including research, clinical practice, health care management, and decision making on the regulation, coverage, and reimbursement of new technologies. Several factors must be considered when selecting which PRO measure to use to ensure their appropriate use and interpretation as well as their relevance for decision makers. The increasing availability of PRO data, its integration with other data sources, and the improvements in data analytics offer a valuable opportunity to place the patient at the center of any health care process. However, several issues need to be addressed, including interoperability, data governance, security, privacy, and ethics, to realize an effective, integrated, standardized, real-time assessment of PROs in the health care systems.

摘要

患者报告的结局(PROs)是指患者健康状况的任何报告,直接来自患者(或在某些情况下来自护理人员或替代响应者),而不由从业者或其他任何人解释。PROs 越来越多地被用作医疗保健不同领域的有价值的数据来源,包括研究、临床实践、医疗保健管理以及对新技术的监管、覆盖范围和报销的决策。在选择要使用的 PRO 测量指标时,必须考虑几个因素,以确保其正确使用和解释以及对决策者的相关性。PRO 数据的可用性不断增加,将其与其他数据源集成以及数据分析的改进为将患者置于任何医疗保健过程的中心提供了宝贵的机会。但是,需要解决一些问题,包括互操作性、数据治理、安全性、隐私和道德问题,以实现医疗保健系统中对 PROs 的有效、集成、标准化、实时评估。

相似文献

1
Value Lies in the Eye of the Patients: The Why, What, and How of Patient-reported Outcomes Measures.价值在于患者眼中:患者报告结局测量的原因、内容和方法。
Clin Ther. 2020 Jan;42(1):25-33. doi: 10.1016/j.clinthera.2019.11.016. Epub 2020 Jan 10.
2
Patient-Reported Outcomes in Health Economic Decision-Making: A Changing Landscape in Oncology.健康经济决策中的患者报告结局:肿瘤学领域不断变化的局面
Recent Results Cancer Res. 2019;213:67-83. doi: 10.1007/978-3-030-01207-6_6.
3
Turning Feed-forward and Feedback Processes on Patient-reported Data into Intelligent Action and Informed Decision-making: Case Studies and Principles.将基于患者报告数据的前馈和反馈过程转化为智能行动和知情决策:案例研究与原则。
Med Care. 2019 May;57 Suppl 5 Suppl 1:S31-S37. doi: 10.1097/MLR.0000000000001088.
4
Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 3: patient-reported outcomes can facilitate shared decision-making and guide self-management.《患者报告结局(PROs)使用系列的蒙特利尔协定》- 论文3:患者报告结局可促进共同决策并指导自我管理。
J Clin Epidemiol. 2017 Sep;89:125-135. doi: 10.1016/j.jclinepi.2017.04.017. Epub 2017 Apr 20.
5
The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy.在比较疗效研究中使用患者报告的结局(PRO):对临床实践和医疗保健政策的影响。
Med Care. 2012 Dec;50(12):1060-70. doi: 10.1097/MLR.0b013e318268aaff.
6
[An introduction to patient reported outcome measures in quality assessment].[质量评估中患者报告结局指标介绍]
Ugeskr Laeger. 2015 May 4;177(19).
7
Measuring what matters: Why and how to include patient reported outcomes in clinical care and research on inborn errors of metabolism.衡量重要指标:为何以及如何将患者报告的结果纳入临床护理和先天性代谢缺陷研究。
J Inherit Metab Dis. 2023 Sep;46(5):796-805. doi: 10.1002/jimd.12622. Epub 2023 May 11.
8
Advancing the use of patient-reported outcomes in practice: understanding challenges, opportunities, and the potential of health information technology.推进患者报告结局在实践中的应用:了解挑战、机遇和健康信息技术的潜力。
Qual Life Res. 2019 Jun;28(6):1575-1583. doi: 10.1007/s11136-019-02112-0. Epub 2019 Jan 25.
9
Integrating the use of patient-reported outcomes for both clinical practice and performance measurement: views of experts from 3 countries.整合患者报告结局在临床实践和绩效评估中的应用:来自三个国家的专家观点
Milbank Q. 2014 Dec;92(4):754-75. doi: 10.1111/1468-0009.12091.
10
ASPECTS OF PATIENT REPORTED OUTCOMES IN RARE DISEASES: A DISCUSSION PAPER.罕见病患者报告结局的相关方面:一篇讨论文件
Int J Technol Assess Health Care. 2016 Jan;32(3):126-30. doi: 10.1017/S0266462316000271. Epub 2016 Aug 15.

引用本文的文献

1
Non-pharmacological rehabilitation interventions for individuals with antiphospholipid syndrome: A scoping review.抗磷脂综合征患者的非药物康复干预措施:范围综述。
Lupus. 2024 Feb;33(2):101-110. doi: 10.1177/09612033231223336. Epub 2023 Dec 19.
2
The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022.在欧洲,对药品授权的患者报告结局评估:对 2017 年至 2022 年欧洲公共评估报告的回顾。
Appl Health Econ Health Policy. 2023 Nov;21(6):925-935. doi: 10.1007/s40258-023-00827-3. Epub 2023 Sep 2.
3
Patient-reported outcome measures in drugs for neurological conditions approved by European Medicines Agency 2017-2022.
2017-2022 年欧洲药品管理局批准用于神经疾病的药物的患者报告结局测量指标。
Neurol Sci. 2023 Aug;44(8):2933-2937. doi: 10.1007/s10072-023-06825-6. Epub 2023 May 5.
4
A brief appraisal on the GRADE methodology and the development of recommendations on the management of prolonged air leaks by the PALAS Study Group.关于GRADE方法的简要评估以及PALAS研究小组关于延长气漏管理建议的制定。
J Thorac Dis. 2023 Feb 28;15(2):839-844. doi: 10.21037/jtd-22-498. Epub 2022 Aug 4.
5
[Not Available].[不可用]。
Glob Reg Health Technol Assess. 2020 May 6;7:9-13. doi: 10.33393/grhta.2020.2102. eCollection 2020 Jan-Dec.
6
A Multicenter Retrospective Cohort Study on Superior Vena Cava Resection in Non-Small-Cell Lung Cancer Surgery.非小细胞肺癌手术中 superior vena cava 切除术的多中心回顾性队列研究。 (注:superior vena cava 一般译为“上腔静脉” )
Cancers (Basel). 2022 Dec 13;14(24):6138. doi: 10.3390/cancers14246138.
7
New Indications in Thoracic Oncology for Mediastinal Lymph Node Staging Using Endobronchial Ultrasound.经支气管超声引导下纵隔淋巴结分期在胸部肿瘤学中的新应用
Front Oncol. 2022 Jul 8;12:934986. doi: 10.3389/fonc.2022.934986. eCollection 2022.
8
Non-invasive electrical stimulation of peripheral nerves for the management of tremor.外周神经无创性电刺激治疗震颤。
J Neurol Sci. 2022 Apr 15;435:120195. doi: 10.1016/j.jns.2022.120195. Epub 2022 Feb 19.
9
An Electronic Patient-Reported Outcome Mobile App for Data Collection in Type A Hemophilia: Design and Usability Study.一款用于甲型血友病数据收集的电子患者报告结局移动应用程序:设计与可用性研究。
JMIR Form Res. 2021 Dec 1;5(12):e25071. doi: 10.2196/25071.
10
Healthcare avoidance: a qualitative study of dental care avoidance in Germany in terms of emergent behaviours and characteristics.医疗保健回避:基于紧急行为和特征的德国牙科保健回避的定性研究。
BMC Oral Health. 2021 Nov 8;21(1):563. doi: 10.1186/s12903-021-01933-1.